An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

ProCAncer-I at the Hellenic Radiological Society Conference 2022 in Athens

Published on: December 15, 2022
Categories: News

The ProCAncer-I project participated at the “Current Developments in Radiology” conference, organized by the Hellenic Radiological Society. The conference was held on December 09-11, 2022 in Athens, Greece at Divani Caravel Hotel.

During the Conference, which was addressed to all Greek Radiologists, the latest scientific and technological developments regarding the role of Radiology and Artificial Intelligence in the diagnostic and therapeutic approach of patients were presented.

Prof. Kostas Marias, delivered a speech concerning the “Artificial Intelligence in Oncology Imaging: Where Are We?” where, among other issues, presented the AI for Health imaging (AI4HI) initiative and discussed the FUTURE-AI guiding principles for trustworthy AI.

Dr. Nickolaos Papanikolaou in his presentation “Introduction to Artificial Intelligence in Radiology” presented the clinical challenges and the main scopes of the ProCAncer -I project.

PAPANIKOLAOU ATHENS

MARIAS2ATHENS (2)

MARIAS2ATHENS (1)

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

Oct 1, 2024

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

May 30, 2024

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Apr 29, 2024

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!